首页 > 最新文献

The Brown University Psychopharmacology Update最新文献

英文 中文
Amitriptyline superior to placebo as second-line treatment for IBS 作为肠易激综合征的二线治疗，阿米替林优于安慰剂
The Brown University Psychopharmacology Update
Pub Date : 2024-01-29 DOI: 10.1002/pu.31137
{"title":"Amitriptyline superior to placebo as second-line treatment for IBS","authors":"","doi":"10.1002/pu.31137","DOIUrl":"https://doi.org/10.1002/pu.31137","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139643899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clozapine is not the end of the story 氯氮平不是故事的终结
The Brown University Psychopharmacology Update
Pub Date : 2024-01-29 DOI: 10.1002/pu.31134
Lawrence H. Price M.D.

As most Update readers are aware, the U.S. Food and Drug Administration (FDA) has approved only one drug with an indication for treatment-resistant schizophrenia: clozapine. You might not know the backstory to this though.

大多数《最新消息》的读者都知道，美国食品和药物管理局（FDA）只批准了一种适用于耐药性精神分裂症的药物：氯氮平。但您可能不知道这背后的故事。
{"title":"Clozapine is not the end of the story","authors":"Lawrence H. Price M.D.","doi":"10.1002/pu.31134","DOIUrl":"https://doi.org/10.1002/pu.31134","url":null,"abstract":"<p>As most <i>Update</i> readers are aware, the U.S. Food and Drug Administration (FDA) has approved only one drug with an indication for treatment-resistant schizophrenia: clozapine. You might not know the backstory to this though.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139655471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Naltrexone, acamprosate show strongest results in review of alcohol use disorder treatments 纳曲酮、阿坎酸在酒精使用障碍治疗综述中显示出最强效果
The Brown University Psychopharmacology Update
Pub Date : 2024-01-29 DOI: 10.1002/pu.31133

A systematic review and meta-analysis of approved and off-label medication treatments for alcohol use disorder has concluded that oral naltrexone and acamprosate have the strongest evidence for reducing alcohol consumption. Trials that directly compared naltrexone and acamprosate did not establish superiority of one of the medications.

一项对已获批准的和标示外的酒精使用障碍药物治疗方法进行的系统回顾和荟萃分析得出结论，口服纳曲酮和阿坎酸酯在减少酒精消费方面具有最有力的证据。直接比较纳曲酮和阿坎酸的试验并未确定其中一种药物的优越性。
{"title":"Naltrexone, acamprosate show strongest results in review of alcohol use disorder treatments","authors":"","doi":"10.1002/pu.31133","DOIUrl":"https://doi.org/10.1002/pu.31133","url":null,"abstract":"<p>A systematic review and meta-analysis of approved and off-label medication treatments for alcohol use disorder has concluded that oral naltrexone and acamprosate have the strongest evidence for reducing alcohol consumption. Trials that directly compared naltrexone and acamprosate did not establish superiority of one of the medications.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139643897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjunctive dextromethorphan/quinidine promising in pilot study for depression 右美沙芬/奎尼丁辅助治疗抑郁症的试点研究前景看好
The Brown University Psychopharmacology Update
Pub Date : 2024-01-29 DOI: 10.1002/pu.31135
{"title":"Adjunctive dextromethorphan/quinidine promising in pilot study for depression","authors":"","doi":"10.1002/pu.31135","DOIUrl":"https://doi.org/10.1002/pu.31135","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139655473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Higher dose of buprenorphine improved retention in treatment 加大丁丙诺啡的剂量可改善治疗的持续性
The Brown University Psychopharmacology Update
Pub Date : 2023-12-26 DOI: 10.1002/pu.31126
{"title":"Higher dose of buprenorphine improved retention in treatment","authors":"","doi":"10.1002/pu.31126","DOIUrl":"https://doi.org/10.1002/pu.31126","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139047465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subcutaneous version of risperidone delays relapse to schizophrenia 利培酮皮下注射剂可延缓精神分裂症复发
The Brown University Psychopharmacology Update
Pub Date : 2023-12-26 DOI: 10.1002/pu.31121
{"title":"Subcutaneous version of risperidone delays relapse to schizophrenia","authors":"","doi":"10.1002/pu.31121","DOIUrl":"https://doi.org/10.1002/pu.31121","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139047139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review finds seven drugs efficacious for treatment of bipolar depression 研究发现七种药物可有效治疗躁郁症
The Brown University Psychopharmacology Update
Pub Date : 2023-12-26 DOI: 10.1002/pu.31127
{"title":"Review finds seven drugs efficacious for treatment of bipolar depression","authors":"","doi":"10.1002/pu.31127","DOIUrl":"https://doi.org/10.1002/pu.31127","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139047466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Your Medication Information 您的用药信息
The Brown University Psychopharmacology Update
Pub Date : 2023-12-26 DOI: 10.1002/pu.31128

Asenapine (generic) – Risperdal Saphris (brand)

阿塞那平（非专利药） - 利培酮 Saphris（品牌药）
{"title":"Your Medication Information","authors":"","doi":"10.1002/pu.31128","DOIUrl":"https://doi.org/10.1002/pu.31128","url":null,"abstract":"<p>Asenapine (generic) – Risperdal Saphris (brand)</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139047467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjunctive cariprazine did not improve outcomes in depression trial 在抑郁症试验中，辅助用药卡哌嗪并未改善疗效
The Brown University Psychopharmacology Update
Pub Date : 2023-12-26 DOI: 10.1002/pu.31123
{"title":"Adjunctive cariprazine did not improve outcomes in depression trial","authors":"","doi":"10.1002/pu.31123","DOIUrl":"https://doi.org/10.1002/pu.31123","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139041917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review finds little benefit from higher-than-recommended doses of stimulants 研究发现，高于推荐剂量的兴奋剂几乎没有什么益处
The Brown University Psychopharmacology Update
Pub Date : 2023-12-26 DOI: 10.1002/pu.31117

A systematic review and meta-analysis of studies involving adults with attention-deficit hyperactivity disorder (ADHD) has found small or no benefit from stimulant doses that exceed levels recommended in regulatory guidelines. Unlicensed doses of methylphenidate or amphetamines also were found to increase risk of treatment dropout due to adverse events. Results of the systematic review and meta-analysis were published online Oct. 25, 2023, in JAMA Psychiatry..

一项针对成人注意力缺陷多动障碍（ADHD）患者研究的系统性回顾和荟萃分析发现，兴奋剂剂量超过监管指南建议的水平对患者的益处很小或没有益处。研究还发现，未经许可的哌醋甲酯或苯丙胺剂量会增加因不良反应而放弃治疗的风险。系统回顾和荟萃分析的结果于2023年10月25日在线发表在《美国医学会精神病学杂志》（JAMA Psychiatry）上。
{"title":"Review finds little benefit from higher-than-recommended doses of stimulants","authors":"","doi":"10.1002/pu.31117","DOIUrl":"https://doi.org/10.1002/pu.31117","url":null,"abstract":"<p>A systematic review and meta-analysis of studies involving adults with attention-deficit hyperactivity disorder (ADHD) has found small or no benefit from stimulant doses that exceed levels recommended in regulatory guidelines. Unlicensed doses of methylphenidate or amphetamines also were found to increase risk of treatment dropout due to adverse events. Results of the systematic review and meta-analysis were published online Oct. 25, 2023, in <i>JAMA Psychiatry.</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139047135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
The Brown University Psychopharmacology Update
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1